These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 19843336

  • 1. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
    Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.
    BMC Cancer; 2009 Oct 20; 9():374. PubMed ID: 19843336
    [Abstract] [Full Text] [Related]

  • 2. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.
    Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, Dagnaes-Hansen F, Øster B, Schepeler T, Tobiasen H, Thorsen K, Sieber OM, Gibbs P, Lamy P, Hansen TF, Jakobsen A, Riising EM, Helin K, Lubinski J, Hagemann-Madsen R, Laurberg S, Ørntoft TF, Andersen CL.
    PLoS One; 2014 Oct 20; 9(6):e96767. PubMed ID: 24892549
    [Abstract] [Full Text] [Related]

  • 3. Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
    Heublein S, Albertsmeier M, Pfeifer D, Loehrs L, Bazhin AV, Kirchner T, Werner J, Neumann J, Angele MK.
    BMC Cancer; 2018 Feb 20; 18(1):201. PubMed ID: 29463215
    [Abstract] [Full Text] [Related]

  • 4. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
    Xu L, Li M, Wang M, Yan D, Feng G, An G.
    BMC Cancer; 2014 Sep 25; 14():714. PubMed ID: 25255814
    [Abstract] [Full Text] [Related]

  • 5. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
    Li Y, Sun Z, Liu B, Shan Y, Zhao L, Jia L.
    Cell Death Dis; 2017 Jun 22; 8(6):e2892. PubMed ID: 28640257
    [Abstract] [Full Text] [Related]

  • 6. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
    Torres S, Garcia-Palmero I, Bartolomé RA, Fernandez-Aceñero MJ, Molina E, Calviño E, Segura MF, Casal JI.
    J Pathol; 2017 May 22; 242(1):39-51. PubMed ID: 28054337
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P, COLOFOL steering group, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, Ørntoft TF, Andersen CL.
    Int J Cancer; 2013 Jul 22; 133(1):67-78. PubMed ID: 23280316
    [Abstract] [Full Text] [Related]

  • 9. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
    Kandhavelu J, Subramanian K, Khan A, Omar A, Ruff P, Penny C.
    Microrna; 2019 Jul 22; 8(1):68-75. PubMed ID: 30073936
    [Abstract] [Full Text] [Related]

  • 10. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, Wang FH, Chiao LJ, Pelicano H, Huang P, Li YH, Xu RH.
    Hepatology; 2014 Aug 22; 60(2):598-609. PubMed ID: 24616020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Distinct shed microvesicle and exosome microRNA signatures reveal diagnostic markers for colorectal cancer.
    Chen M, Xu R, Rai A, Suwakulsiri W, Izumikawa K, Ishikawa H, Greening DW, Takahashi N, Simpson RJ.
    PLoS One; 2019 Aug 22; 14(1):e0210003. PubMed ID: 30608951
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
    Liu H, Liu Y, Sun P, Leng K, Xu Y, Mei L, Han P, Zhang B, Yao K, Li C, Bai J, Cui B.
    Clin Sci (Lond); 2020 Feb 28; 134(4):419-434. PubMed ID: 32065214
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer.
    Emami SS, Akbari A, Zare AA, Agah S, Masoodi M, Talebi A, Minaeian S, Fattahi A, Moghadamnia F.
    J Gastrointest Cancer; 2019 Jun 28; 50(2):276-284. PubMed ID: 29404790
    [Abstract] [Full Text] [Related]

  • 20. Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer.
    Feng H, Xu M, Zhang Y, Han B, Wang J, Sun P.
    Clin Lab; 2018 May 01; 64(5):797-804. PubMed ID: 29739047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.